This effect, as shown in our studies, is significantly more potent than ADCC mediated by the single anti-GPC3 antibody via Fc binding to CD16 on NK cells against HCC tumors and is an effective way of targeting NK cells against tumors. The gene discussed is GPC3; the disease is hepatocellular carcinoma.